Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Deacon RM; Wand H; Stelzer-Braid S; Treloar C; Maher L, 2011, 'Improving surveillance for acute hepatitis C', Communicable Diseases Intelligence Quarterly Report, 35, pp. 16 - 20, http://search.informit.com.au/documentSummary;dn=057496644726691;res=IELHEA

Drummond F; Ryder N; Wand H; Guy R; Read P; McNulty A; Wray L; Donovan B, 2011, 'Is azithromycin adequate treatment for asymptomatic rectal chlamydia?', International Journal of STD and AIDS, 22, pp. 478 - 480, http://dx.doi.org/10.1258/ijsa.2011.010490

Drummond F; Ryder N; Wand H; Guy R; Read P; McNulty A; Wray L; Donovan B, 2011, 'IS SINGLE DOSE AZITHROMYCIN ADEQUATE FOR ASYMPTOMATIC RECTAL CHLAMYDIA?', SEXUALLY TRANSMITTED INFECTIONS, 87, pp. A76 - A76, http://dx.doi.org/10.1136/sextrans-2011-050109.122

Drummond F; Lewis L; Bourne C; Ramanathan V; Hocking J; Wand H; Donovan B; Kaldor J; Guy R, 2011, 'P1-S6.32 Optimising clinical systems to increase HIV/STI testing in gay men: the eTEST project', Sexually Transmitted Infections, 87, pp. a209, http://dx.doi.org/10.1136/sextrans-2011-050108.256

Wand HC; Guy R; Donovan B; McNulty A, 2011, 'Population attributable risk for chlamydia infection in a cohort of young international travellers (backpackers) and residents in Australia', BMJ Open, 1, pp. e000004, http://dx.doi.org/10.1136/bmjopen-2010-000004

Wand H, 2011, 'POPULATION ATTRIBUTABLE RISK FOR CHLAMYDIA INFECTION IN A COHORT OF YOUNG INTERNATIONAL TRAVELLERS (BACKPACKERS) AND RESIDENTS IN AUSTRALIA', SEXUALLY TRANSMITTED INFECTIONS, 87, pp. A179 - A179, http://dx.doi.org/10.1136/sextrans-2011-050108.190

Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK, 2011, 'Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data', Lancet Infectious Diseases, 11, pp. 39 - 44

Guy R; Wand HC; Franklin NP; Fairley CK; Chen M; O'Connor CC; Marshall L; Grulich AE; Kaldor JM; Hellard M; Donovan B, 2011, 'Re-testing for chlamydia at sexual health services in Australia, 2004-08', Sexual Health, 8, pp. 242 - 247, http://search.informit.com.au/documentSummary;dn=026882672949469;res=IELHEA

Bourne CP; Knight V; Guy R; Wand HC; Lu H; McNulty A, 2011, 'Short message service reminder intervention doubles sexually transmitted infection/HIV re-testing rates among men who have sex with men', Sexually Transmitted Infections, 87, pp. 229 - 231, http://dx.doi.org/10.1136/sti.2010.048397

Guy R; Wand H; Read P; Kenigsberg A; Knight V; McNulty A, 2011, 'SMS REMINDERS INCREASE RE-TESTING FOR REPEAT CHLAMYDIAL INFECTION IN HETEROSEXUALS AT A SEXUAL HEALTH CLINIC', SEXUALLY TRANSMITTED INFECTIONS, 87, pp. A324 - A324, http://dx.doi.org/10.1136/sextrans-2011-050108.548

Yan P; Zhang F; Wand HC, 2011, 'Using HIV diagnostic data to estimate HIV incidence: method and simulation', Statistical Communications in Infectious Diseases, 3, pp. 1 - 28, http://dx.doi.org/10.2202/1948-4690.1011

Wand H; Ramjee G, 2010, 'Targeting the hotspots: Investigating spatial and demographic variations in HIV infection in small communities in South Africa', Journal of the International AIDS Society, 13, pp. 41 - 41, http://dx.doi.org/10.1186/1758-2652-13-41

Wand H; Yan P; Wilson D; McDonald A; Middleton M; Kaldor J; Law M, 2010, 'Increasing HIV transmission through male homosexual and heterosexual contact in Australia: Results from an extended back-projection approach', HIV Medicine, 11, pp. 395 - 403, http://dx.doi.org/10.1111/j.1468-1293.2009.00804.x

Falster K; Wand H; Donovan B; Anderson J; Nolan D; Watson K; Watson J; Law MG; Australian HIV Observational Database , 2010, 'Hospitalizations in a cohort of HIV patients in Australia, 1999-2007.', AIDS, 24, pp. 1329 - 1339, http://dx.doi.org/10.1097/QAD.0b013e328339e245

Raboud JM; Diong C; Carr AD; Grinspoon SK; Mulligan K; Sutinen J; Rozenbaum W; Cavalcanti RB; Wand HC; Costagiola D; Walmsley S, 2010, 'A Meta-Analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy', HIV Clinical Trials, 11, pp. 39 - 50

Iversen J; Wand H; Gonnermann A; Maher L, 2010, 'Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008', International Journal of Drug Policy, 21, pp. 471 - 476, http://dx.doi.org/10.1016/j.drugpo.2010.04.004

Calmy A; Bloch M; Wand HC; Delhumeau C; Finlayson R; Rafferty M; Norris R; Hirschel B; Cooper DA; Carr AD, 2010, 'No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial', HIV Medicine, 11, pp. 497 - 501

Wand H; Ramjee G, 2010, 'Targeting the hotspots: Investigating spatial and demographic variations in HIV infection in small communities in South Africa', Journal of the International AIDS Society, 13, pp. 1 - 9, http://www.jiasociety.org/content/13/1/41

McNulty A; Egan C; Wand H; Donovan B, 2010, 'The behaviour and sexual health of young international travellers (backpackers) in Australia', Sexually Transmitted Infections, 86, pp. 247 - 250, http://dx.doi.org/10.1136/sti.2009.038737

Harcourt CL; O Connor J; Egger SJ; Fairley CK; Wand HC; Chen M; Marshall L; Kaldor JM; Donovan BJ, 2010, 'The decriminalisation of prostitution is associated with better coverage of health promotion programs for sex workers', Australian and New Zealand Journal of Public Health, 34, pp. 482 - 486

Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L, 2009, 'Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: Implications for prevention policy and planning', Addiction, 104, pp. 2049 - 2056, http://dx.doi.org/10.1111/j.1360-0443.2009.02704.x

Nakhaee F; Black D; Wand H; McDonald A; Law M, 2009, 'Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 19812003', Sexual Health, 6, pp. 129 - 134, http://dx.doi.org/10.1071/SH08007

Klug GM; Wand H; Boyd A; Law M; Whyte S; Kaldor J; Masters CL; Collins S, 2009, 'Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster', Brain, 132, pp. 493 - 501, http://dx.doi.org/10.1093/brain/awn303

Chen M; Millwood I; Wand HC; Poynten IM; Law MG; Kaldor JM; Wesselingh S; Price C; Clark L; Pauli J; Fairley CK, 2009, 'A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 375 - 380

Wand HC; Wilson DP; Yan P; Gonnermann A; McDonald AM; Kaldor JM; Law MG; Han A, 2009, 'Characterizing trends in HIV infection among men who have sex with men in Australia by birth-cohorts: results from a modified back-projection method', Journal of the International AIDS Society, 12, pp. 19 - 19, http://dx.doi.org/10.1186/1758-2652-12-19

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2009, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism', Current HIV Research, 7, pp. 454 - 461

Read TRH; Carey DL; Mallon PW; Mijch A; Goodall R; Hudson F; Wand HC; Emery S, 2009, 'Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial', AIDS, 23, pp. 2222 - 2223, http://dx.doi.org/10.1097/QAD.0b013e32832e95f8

McDonald AM; Zurynski Y; Wand HC; Giles M; Elliot E; Ziegler JB; Kaldor JM, 2009, 'Perinatal exposure to HIV among children born in Australia, 1982-2006', Medical Journal of Australia, 190, pp. 416 - 420

Topp L; Iversen J; Wand H; Day C; Kaldor J; Maher L, 2008, 'Representativeness of injecting drug users who participate in HIV surveillance: Results from Australia's needle and syringe program survey', Journal of Acquired Immune Deficiency Syndromes, 47, pp. 632 - 638, http://dx.doi.org/10.1097/QAI.0b013e31816a1d68

Calmy A; Carey D; Mallon PWG; Wand H; Law M; Cooper DA; Carr A; Yeni P; Aboulker JP; Antunes F; Babiker A; Becker M; Boukli N; Brun-Vezinet F; Carey D; Churchill D; Conway B; Chazallon C; Darbyshire J; De Wit S; Dusak B; Emery S; Flepp M; Floridia M; Gatell J; Girard PM; Goodall RL; Hemmer R; Hooker M; Law M; Loveday C; Lundgren J; Manion D; Mulcahy F; Orani A; Pharo C; Ristola M; Salzberger B; Sandstrom E; Schechter M; Schnittman S; Seligmann M; Staszewski S; Stek M; Verbiest W; Weber J; Lee W; Phipps S; Sharkey T; Dimayuga R; Jones M; Jutha S; Kraus D; Zastre B; Dragsted U; Grønholdt A; Ludgren J; Mollerup D; Skinnes L; Kahi S; Léger L; Meiffrédy V; Rodier AS; Saïdi Y; Cruceta A; Lenz B; Rochon J; Schade-Brittinger C; Wittenberg M; Wolf H; Bucciardini R; Fragola V; Galluzzo CM; Germinario E; Guidi M; Innocenti F; Massella M; Mattei A; Mirra M; Paoloni MI; Polizzi C; Pirillo M; Vella S; Gremlich E; Mosimann A; Hudson F; Johnson D; Kelleher P; Poland A; Taylor K; Wait J; Withnall R; Mallon P; Norris R; Rafferty M; Lacey M; Chisholm D; Samaras K, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, 9, pp. 101 - 110, http://dx.doi.org/10.1111/j.1468-1293.2007.00527.x

Donovan B; O'Connor JL; Harcourt C; Egger S; Wand H; Chen MY; Tabrizi S; Marshall L; Kaldor JM; Fairley CK, 2008, 'THE LAW AND SEXWORKER HEALTH (LASH) PROJECT', SEXUAL HEALTH, 5, pp. 382 - 383, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260999000023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Connor JL; Harcourt C; Wand H; Egger S; Fairley CK; Kaldor JM; Marshall L; Bates JL; Donovan B, 2008, 'THE SEX INDUSTRY IN PERTH BEFORE DECRIMINALISATION', SEXUAL HEALTH, 5, pp. 384 - 384, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260999000027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Herzmann C; Cuthbertson Z; Fosdick L; Fisher M; Nelson M; Perry NB; Law MG; Wand HC; Janossy G; Johnson MA; Youle M, 2008, 'Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients', Journal of Antimicrobial Chemotherapy, 62, pp. 583 - 586, http://dx.doi.org/10.1093/jac/dkn238

Donovan BJ; O Connor J; Harcourt CL; Egger SJ; Wand HC; Chen M; Tabrizi S; Marshall L; Kaldor JM; Fairley CK, 2008, 'THE LAW AND SEXWORKER HEALTH (LASH) PROJECT', Sexual Health, 5, pp. 4 - 5

O Connor J; Harcourt CL; Wand HC; Egger SJ; Fairley CK; Kaldor JM; Marshall L; Bates J; Donovan BJ, 2008, 'THE SEX INDUSTRY IN PERTH BEFORE DECRIMINALISATION', Sexual Health, 5, pp. 8 - 9

Wand H; Calmy A; Carey DL; Samaras K; Carr A; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection', AIDS, 21, pp. 2445 - 2453, http://dx.doi.org/10.1097/QAD.0b013e3282efad32

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455, http://dx.doi.org/10.2337/dc07-er02

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (vol 30, pg 113, 2007)', DIABETES CARE, 30, pp. 455 - 455, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000244024100062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor J, 2007, 'Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia', Drug and Alcohol Dependence, 89, pp. 244 - 250, http://dx.doi.org/10.1016/j.drugalcdep.2007.01.001

Spiegelman D; Hertzmark E; Wand HC, 2007, 'Point and interval estimates of partial population attributable risks in cohort studies: examples and software', Cancer Causes and Control, 18, pp. 571 - 579, http://dx.doi.org/10.1007/s10552-006-0090-y

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, 30, pp. 113 - 119, http://dx.doi.org/10.2337/dc06-1075

Spillane H; Mcnulty A; Wand HC; Tribe KL; Donovan BJ, 2007, 'Who declines to give a name at a sexual health service?', Sexually Transmitted Infections, 83, pp. 160 - 162, http://dx.doi.org/10.1136/sti.2006.021709

Group* ER; Group: W; Pett SL; Wand H; Law MG; Arduino R; Lopez JC; Knysz B; Pereira LC; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of Subcutaneous Proleukin (Interleukin-2) in a Randomized International Trial (ESPRIT): Geographical and Gender Differences in the Baseline Characteristics of Participants', HIV Research & Clinical Practice, 7, pp. 70 - 85, http://dx.doi.org/10.1310/hct.2006.7.2.005

Pett SL; Wand H; Law MG; Arduino R; Lopez JC; Knysz B; Pereira LC; Pollack S; Reiss P; Tambussi G; Abrams DI; Cooper DA; Darbyshire JH; Duncan WR; Emery S; Clifford Lane H; Lehrman S; Lundgren JD; Neaton JD; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ines F; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Losso M; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; del Lujan Sanchez M; Somenzini C; Tocci M; Algar S; Anderson J; Austin D; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Ferguson W; Finlayson R; French M; Gold J; Habel P; Hoy J; Hudson J; James R; Jeganathan S; Leung J; Lowe K; MacRae K; Mallal S; McMurchie M; Medland N; Mijch A; Miller S; Murray J; Orth D; Patching J; Primrose R; Quan D; Rawlinson M; Ree H; Richardson R; Rogers G; Roney J; Roth N; Shaw D; Soo TM; Sowden D; Street A; Street A; Vale R, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85, http://dx.doi.org/10.1310/4733-ACQF-F3P4-2QAC

Youle M; Emery S; Fisher M; Nelson M; Fosdick L; Janossy G; Loveday C; Sullivan AM; Herzmann C; Wand HC; Davey Jr R; Johnson MA; Tavel JA; Lane HC; Sullaphen J, 2006, 'A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: The UK-Vanguard study.', PLoS Clinical Trials, 1, pp. e3 - e3, http://dx.doi.org/10.1371/journal.pctr.0010003

Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, 20, pp. 294 - 297

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24

Calmy A; Carey DL; Mallon PW; Wand HC; Cooper DA; Law MG; Carr AD, 2006, 'Early changes in adiponectin and leptin levels predict changes in limb fat mass over 2 years following initiation of antiretroviral therapy', Antiviral Therapy, 11, pp. L12 - L12

Spillane H; Mcnulty A; Wand HC; Tribe KL; Donovan BJ, 2006, 'Who declines to give a name in a sexual health service?', Sexually Transmitted Infections, 83, pp. 160 - 162, http://dx.doi.org/10.1136/sti.2006.021709

Mallon PWG; Wand H; Law M; Miller J; Cooper DA; Carr A, 2005, 'Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia', Journal of Acquired Immune Deficiency Syndromes, 38, pp. 156 - 162, http://dx.doi.org/10.1097/01.qai.0000147527.64863.1a


Back to profile page